The Effects of Combined Neuro-vestibular-ocular Exercises and Myofascial Release on Proprioception and Performance in Soccer Players With Chronic Ankle Instability

NCT05799885 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2023-04-05

No results posted yet for this study

Summary

Chronic ankle instability was first defined by Freeman as recurrent ankle sprains following an ankle sprain and the feeling of dislocation in the ankle lasting longer than six months. The recurrence of ankle sprains in athletes leads to the realization of ankle instability. Functional ankle instability gives the feeling that a re-sprain will occur at any time due to decreased static and dynamic support in the joint.Neuro-vestibular-ocular exercises is an approach that combines neuromuscular training and vestibular-ocular training techniques.At the same time, we are doing this study because of the mixed studies on the effect of fascial relaxation on the performance and proprioception of a specific group of football players.

Conditions

  • Ankle Inversion Sprain
  • Ankle Injuries

Interventions

OTHER

Neuro-vestibular-ocular group

Neuro-vestibular-ocular exercise group (30 footballers)will do the exercises given in addition to their training

OTHER

Myofascial Release group

Manual myofascial release will be applied by the physiotherapist.(30 football players)

Sponsors & Collaborators

  • Yeditepe University

    lead OTHER

Principal Investigators

  • Büşra Kocakılıç, master · Yeditepe University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-02
Primary Completion
2023-09-03
Completion
2023-09-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05799885 on ClinicalTrials.gov